AGT and familial pancreatic carcinoma: Algenpantucel-L, created from allogenic irradiated pancreatic cancer cells to express α-GT to cause hyperacute rejection, demonstrated efficacy in animal models of melanoma and subsequently in a phase II trial in pancreatic cancer [59].